Persistent diastolic dysfunction despite successful long-term octreotide treatment in acromegaly

被引:0
|
作者
Pereira, AM [1 ]
van Thiel, SW [1 ]
Romijn, JA [1 ]
Bax, JJ [1 ]
机构
[1] Hosp Dept Endocrinol, Leiden, Netherlands
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页数:1
相关论文
共 50 条
  • [31] Dexamethasone implant for the treatment of persistent diabetic macular oedema despite long-term treatment with bevacizumab
    Joe, Aaron W.
    Wickremasinghe, Sanjeewa S.
    Gillies, Mark C.
    Vuong Nguyen
    Lim, Lyndell L.
    Mehta, Hemal
    Fraser-Bell, Samantha
    CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, 2019, 47 (02): : 287 - 289
  • [32] LONG-TERM APPLICATION OF PARLODEL IN THE TREATMENT OF ACROMEGALY
    PISARSKAYA, IV
    ZEFIROVA, GS
    IBRAGIMOVA, GV
    TERAPEVTICHESKII ARKHIV, 1984, 56 (10) : 107 - 110
  • [33] DIASTOLIC DYSFUNCTION IN LONG-TERM SURVIVORS OF CARDIAC TRANSPLANT
    URETSKY, BF
    BERNARDI, L
    GREENBERG, ML
    REDDY, PS
    THOMPSON, ME
    HARDESTY, RL
    GRIFFITH, BP
    BAHNSON, HT
    CIRCULATION, 1984, 70 (04) : 46 - 46
  • [34] DIASTOLIC DYSFUNCTION IN LONG-TERM SURVIVORS OF CARDIAC TRANSPLANT
    URETSKY, BF
    BERNARDI, L
    GREENBERG, ML
    REDDY, PS
    THOMPSON, ME
    HARDESTY, RL
    GRIFFITH, BP
    BAHNSON, HT
    CLINICAL RESEARCH, 1984, 32 (04): : A782 - A782
  • [35] Long-term therapy with long-acting octreotide (Sandostatin-LAR®) for the management of acromegaly
    Davies, PH
    Stewart, SE
    Lancranjan, I
    Sheppard, MC
    Stewart, PM
    CLINICAL ENDOCRINOLOGY, 1998, 48 (03) : 311 - 316
  • [36] Cognitive Dysfunction, an Increasingly Valued Long-Term Impairment in Acromegaly
    Chen, Juan
    Xiang, Zhigao
    Zhang, Zhuo
    Yang, Yan
    Shu, Kai
    Lei, Ting
    JOURNAL OF CLINICAL MEDICINE, 2023, 12 (06)
  • [37] Economics of Acromegaly Treatment in Brazil: A Budget Impact Analysis of Pituitary Surgery Compared with Long-Term Octreotide LAR
    Porto, Lara Benigno
    Zimmermann, Ivan Ricardo
    Naves, Luciana Ansaneli
    PHARMACOECONOMICS-OPEN, 2019, 3 (02) : 247 - 254
  • [38] Economics of Acromegaly Treatment in Brazil: A Budget Impact Analysis of Pituitary Surgery Compared with Long-Term Octreotide LAR
    Lara Benigno Porto
    Ivan Ricardo Zimmermann
    Luciana Ansaneli Naves
    PharmacoEconomics - Open, 2019, 3 : 247 - 254
  • [39] Long-Term Efficacy of Cabergoline Addition to Ongoing Octreotide LAR Therapy in Patients with Acromegaly
    Ramirez, Claudia
    Espinosa de los Monteros, Ana Laura
    Sosa, Ernesto
    Manuel Franco, Juan
    Vargas, Guadalupe
    Gonzalez, Baldomero
    Mercado, Moises
    ENDOCRINE REVIEWS, 2014, 35 (03)
  • [40] Long-Term Remission of Acromegaly after Octreotide Withdrawal Is an Uncommon and Frequently Unsustainable Event
    Casagrande, Alessandra
    Bronstein, Marcello D.
    Jallad, Raquel S.
    Moraes, Aline B.
    Elias, Paula C. L.
    Castro, Margaret
    Czepielewski, Mauro A.
    Boschi, Artur
    Ribeiro-Oliveira, Antonio, Jr.
    Schweizer, Junia R. O. L.
    Vilar, Lucio
    Nazato, Debora M.
    Gadelha, Monica R.
    Abucham, Julio
    NEUROENDOCRINOLOGY, 2017, 104 (03) : 273 - 279